HSD11B1 and obesity due to melanocortin 4 receptor deficiency: Therefore, it fulfils the prerequisites to evaluate the effect of 11beta-HSD1 inhibition in improving glucose metabolism, body weight and lipid profile in patients with T2DM and obesity.